KPTI
Karyopharm Therapeutics Inc.
Company overview
- Market capitalization
- $36.74M
- Employees
- 228
- Latest publication
- 2026-09-29
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compounds include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also develops Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating other myeloproliferative neoplasms and TP53 wild-type solid tumors. In addition, the company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, the company has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed or refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 33,432,000USD | 35,066,000USD | 34,079,000USD | 44,044,000USD | 37,929,000USD | 30,015,000USD | 30,542,000USD | 38,783,000USD |
| Research Development | 28,957,000USD | 33,785,000USD | 27,667,000USD | 30,544,000USD | 32,788,000USD | 34,618,000USD | 33,302,000USD | 36,134,000USD |
| Selling General Administrative | 25,916,000USD | 26,684,000USD | 22,772,000USD | 26,607,000USD | 28,477,000USD | 27,352,000USD | 27,190,000USD | 27,632,000USD |
| Total Operating Expenses | 55,958,000USD | 60,469,000USD | 50,439,000USD | 57,151,000USD | 61,265,000USD | 61,970,000USD | 60,492,000USD | 63,766,000USD |
| Operating Income | -22,526,000USD | -26,760,000USD | -17,844,000USD | -15,220,000USD | -24,387,000USD | -33,256,000USD | -31,281,000USD | -26,283,000USD |
| Total Other Income Expense Net | -44,497,000USD | 4,369,000USD | -84,421,000USD | -17,873,000USD | -12,825,000USD | 9,830,000USD | 392,000USD | -5,761,000USD |
| Interest Income | 722,000USD | 511,000USD | 607,000USD | 553,000USD | 613,000USD | 1,000,000USD | 1,482,000USD | 1,832,000USD |
| Interest Expense | 13,144,000USD | 12,553,000USD | 12,619,000USD | 11,008,000USD | 11,228,000USD | 10,994,000USD | 11,204,000USD | 11,385,000USD |
| Income Before Tax | -67,023,000USD | -22,391,000USD | -102,265,000USD | -33,093,000USD | -37,212,000USD | -23,426,000USD | -30,889,000USD | -32,044,000USD |
| Income Tax Expense | 0USD | 1,000USD | -67,000USD | 34,000USD | 40,000USD | 36,000USD | -109,000USD | 28,000USD |
| Net Income | -67,023,000USD | -22,392,000USD | -102,198,000USD | -33,127,000USD | -37,252,000USD | -23,462,000USD | -30,780,000USD | -32,072,000USD |
| Cost Of Revenue | — | 1,357,000USD | 1,484,000USD | 2,113,000USD | 1,051,000USD | 1,301,000USD | 1,331,000USD | 1,300,000USD |
| Gross Profit | — | 33,709,000USD | 32,595,000USD | 41,931,000USD | 36,878,000USD | 28,714,000USD | 29,211,000USD | 37,483,000USD |
| Net Interest Income | — | -12,042,000USD | -12,012,000USD | -10,455,000USD | -10,615,000USD | -9,994,000USD | -9,722,000USD | -9,553,000USD |
| Tax Provision | — | 1,000USD | -67,000USD | 34,000USD | 40,000USD | 36,000USD | -109,000USD | 28,000USD |
| Net Income From Continuing Ops | — | -22,392,000USD | -102,198,000USD | -33,127,000USD | -37,252,000USD | -23,462,000USD | -30,780,000USD | -32,072,000USD |
| Ebit | — | -26,760,000USD | -89,646,000USD | -22,638,000USD | -25,984,000USD | -12,432,000USD | -19,685,000USD | -20,659,000USD |
| Ebitda | — | -26,748,000USD | -89,627,000USD | -22,560,000USD | -25,906,000USD | -12,354,000USD | -19,604,000USD | -20,576,000USD |
| Depreciation And Amortization | — | 12,000USD | 19,000USD | 78,000USD | 78,000USD | 78,000USD | 81,000USD | 83,000USD |
| Reconciled Depreciation | — | 12,000USD | 19,000USD | 121,000USD | 78,000USD | 78,000USD | 81,000USD | 83,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 146,067,000USD | 145,237,000USD | 146,033,000USD | 157,074,000USD | 209,819,000USD | 108,085,000USD | 40,893,000USD | 30,336,000USD |
| Cost Of Revenue | 5,949,000USD | 6,007,000USD | 4,942,000USD | 5,213,000USD | 3,402,000USD | 2,705,000USD | 2,407,000USD | 161,372,000USD |
| Gross Profit | 140,118,000USD | 139,230,000USD | 141,091,000USD | 151,861,000USD | 206,417,000USD | 105,380,000USD | 38,486,000USD | -131,036,000USD |
| Research Development | 125,617,000USD | 143,232,000USD | 138,750,000USD | 148,662,000USD | 160,842,000USD | 150,813,000USD | 122,340,000USD | 161,372,000USD |
| Selling General Administrative | 105,208,000USD | 115,441,000USD | 131,881,000USD | 145,401,000USD | 143,846,000USD | 126,417,000USD | 105,421,000USD | 48,847,000USD |
| Total Operating Expenses | 230,825,000USD | 258,673,000USD | 270,631,000USD | 294,063,000USD | 304,688,000USD | 277,230,000USD | 227,761,000USD | 210,219,000USD |
| Operating Income | -90,707,000USD | -119,443,000USD | -129,540,000USD | -142,202,000USD | -98,271,000USD | -171,850,000USD | -189,275,000USD | -179,883,000USD |
| Interest Income | 2,773,000USD | 7,400,000USD | 9,757,000USD | 2,359,000USD | 582,000USD | 2,820,000USD | 5,422,000USD | 4,028,000USD |
| Interest Expense | 45,849,000USD | 37,422,000USD | 23,823,000USD | 24,996,000USD | 26,046,000USD | 27,140,000USD | 15,647,000USD | 2,493,000USD |
| Net Interest Income | -43,076,000USD | -30,022,000USD | -13,743,000USD | -22,637,000USD | -25,464,000USD | -24,320,000USD | -10,225,000USD | 1,535,000USD |
| Income Before Tax | -195,996,000USD | -76,365,000USD | -142,776,000USD | -164,922,000USD | -123,820,000USD | -195,964,000USD | -199,550,000USD | -178,381,000USD |
| Income Tax Expense | 43,000USD | 57,000USD | 323,000USD | 369,000USD | 268,000USD | 309,000USD | 40,000USD | 26,000USD |
| Tax Provision | 43,000USD | 57,000USD | 266,000USD | 369,000USD | 268,000USD | 309,000USD | 40,000USD | 26,000USD |
| Net Income | -196,039,000USD | -76,422,000USD | -143,099,000USD | -165,291,000USD | -124,088,000USD | -196,273,000USD | -199,590,000USD | -178,407,000USD |
| Net Income From Continuing Ops | -196,039,000USD | -76,422,000USD | -139,768,000USD | -165,291,000USD | -124,088,000USD | -196,273,000USD | -199,590,000USD | -178,407,000USD |
| Ebit | -150,147,000USD | -38,943,000USD | -118,953,000USD | -139,926,000USD | -97,774,000USD | -168,824,000USD | -183,903,000USD | -175,888,000USD |
| Ebitda | -149,851,000USD | -38,603,000USD | -118,423,000USD | -139,305,000USD | -96,985,000USD | -167,852,000USD | -182,929,000USD | -175,153,000USD |
| Depreciation And Amortization | 296,000USD | 340,000USD | 530,000USD | 621,000USD | 789,000USD | 972,000USD | 974,000USD | 735,000USD |
| Reconciled Depreciation | 296,000USD | 340,000USD | 566,000USD | 621,000USD | 789,000USD | 972,000USD | 974,000USD | 735,000USD |
| Total Other Income Expense Net | -105,289,000USD | 43,078,000USD | -13,236,000USD | -22,720,000USD | -25,549,000USD | -24,114,000USD | -10,275,000USD | 1,502,000USD |
| Non Operating Income Net Other | — | — | — | 2,276,000USD | 497,000USD | 3,026,000USD | 5,372,000USD | 3,995,000USD |
| Net Income Applicable To Common Shares | — | — | — | -165,291,000USD | -124,088,000USD | -196,273,000USD | -199,590,000USD | -178,407,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 111,317,000USD | 131,417,000USD | 108,416,000USD | 96,232,000USD | 104,879,000USD | 127,711,000USD | 164,418,000USD | 189,476,000USD |
| Cash And Equivalents | 54,980,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 106,378,000USD | 126,333,000USD | 103,146,000USD | 89,746,000USD | 97,870,000USD | 120,238,000USD | 156,492,000USD | 184,755,000USD |
| Other Current Assets | 7,408,000USD | 8,527,000USD | 9,186,000USD | 8,026,000USD | 8,249,000USD | 10,285,000USD | 12,275,000USD | 14,779,000USD |
| Total Liabilities | 441,485,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 134,233,000USD | 117,302,000USD | 92,060,000USD | 87,157,000USD | 99,216,000USD | 90,370,000USD | 92,264,000USD | 61,493,000USD |
| Other Current Liabilities | 6,394,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 336,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -330,168,000USD | -265,646,000USD | -292,926,000USD | -269,258,000USD | -238,926,000USD | -205,884,000USD | -186,017,000USD | -159,647,000USD |
| Total Equity Including Noncontrolling Interest | -330,168,000USD | — | — | — | — | — | — | — |
| Inventory | 3,994,000USD | 3,599,000USD | 4,038,000USD | 3,966,000USD | 4,992,000USD | 4,769,000USD | 4,739,000USD | 4,672,000USD |
| Property Plant Equipment Net | 4,354,000USD | 4,500,000USD | 4,652,000USD | 4,802,000USD | 5,325,000USD | 5,799,000USD | 6,284,000USD | 3,081,000USD |
| Accounts Payable | 7,660,000USD | 4,279,000USD | 4,003,000USD | 5,392,000USD | 2,597,000USD | 5,872,000USD | 5,107,000USD | 5,783,000USD |
| Short Term Debt | 1,068,000USD | 33,250,000USD | 21,979,000USD | 14,594,000USD | 32,117,000USD | 25,386,000USD | 24,864,000USD | 3,668,000USD |
| Common Stock | 14,000USD | 14,000USD | 14,000USD | 13,000USD | 13,000USD | 13,000USD | 13,000USD | 13,000USD |
| Retained Earnings | -1,848,914,000USD | -1,781,891,000USD | -1,759,499,000USD | -1,657,301,000USD | -1,624,174,000USD | -1,586,922,000USD | -1,563,460,000USD | -1,532,680,000USD |
| Accumulated Other Comprehensive Income | 41,000USD | 43,000USD | 70,999USD | -259,000USD | -251,000USD | -321,000USD | -356,000USD | -222,000USD |
| Total Liab | — | 397,063,000USD | 401,342,000USD | 365,490,000USD | 343,805,000USD | 333,595,000USD | 350,435,000USD | 349,123,000USD |
| Other Current Liab | — | 79,773,000USD | 66,078,000USD | 67,171,000USD | 64,502,000USD | 59,112,000USD | 62,293,000USD | 52,042,000USD |
| Capital Stock | — | 14,000USD | 14,000USD | 13,000USD | 13,000USD | 13,000USD | 13,000USD | 13,000USD |
| Cash | — | 90,850,000USD | 60,540,000USD | 37,672,000USD | 38,725,000USD | 38,783,000USD | 62,476,000USD | 72,828,000USD |
| Cash And Short Term Investments | — | 90,850,000USD | 63,744,000USD | 45,877,000USD | 51,697,000USD | 69,941,000USD | 108,712,000USD | 133,526,000USD |
| Net Debt | — | 140,024,000USD | 173,067,000USD | 158,751,000USD | 151,893,000USD | 147,920,000USD | 132,048,000USD | 121,432,000USD |
| Short Long Term Debt | — | 32,232,000USD | 21,010,000USD | 12,750,000USD | 30,734,000USD | 24,459,000USD | 24,426,000USD | — |
| Short Long Term Debt Total | — | 230,874,000USD | 233,607,000USD | 196,423,000USD | 190,618,000USD | 186,703,000USD | 194,524,000USD | 194,260,000USD |
| Long Term Debt | — | 192,156,000USD | 205,885,000USD | 176,743,000USD | 152,250,000USD | 154,832,000USD | 162,948,000USD | 190,592,000USD |
| Short Term Investments | — | 0USD | 3,204,000USD | 8,205,000USD | 12,972,000USD | 31,158,000USD | 46,236,000USD | 60,698,000USD |
| Net Receivables | — | 23,357,000USD | 26,178,000USD | 31,877,000USD | 32,932,000USD | 35,243,000USD | 30,766,000USD | 31,778,000USD |
| Property Plant Equipment Gross | — | 4,500,000USD | 10,162,000USD | 4,802,000USD | 5,325,000USD | 5,799,000USD | 12,975,000USD | 3,081,000USD |
| Common Stock Shares Outstanding | — | 24,715,000shares | 17,979,000shares | 8,669,000shares | 8,620,000shares | 8,470,000shares | 8,392,066shares | 8,333,999shares |
| Non Current Assets Total | — | 5,084,000USD | 5,270,000USD | 6,486,000USD | 7,009,000USD | 7,473,000USD | 7,926,000USD | 4,721,000USD |
| Non Current Liabilities Total | — | 279,760,999USD | 309,282,000USD | 278,333,000USD | 244,589,000USD | 243,225,000USD | 258,171,000USD | 287,630,000USD |
| Non Current Liabilities Other | — | 278,000USD | 11,095,000USD | 14,118,000USD | 8,256,000USD | 5,146,000USD | 2,430,000USD | 6,184,000USD |
| Non Currrent Assets Other | — | 267,000USD | 267,000USD | 1,334,000USD | 1,684,000USD | 1,674,000USD | 1,642,000USD | 1,640,000USD |
| Net Working Capital | — | 9,031,000USD | 11,086,000USD | 2,589,000USD | -1,346,000USD | 29,868,000USD | 64,228,000USD | 123,262,000USD |
| Unclassified Current Liabilities | — | -32,232,000USD | -21,010,000USD | -12,750,000USD | -30,734,000USD | -24,459,000USD | -24,426,000USD | — |
| Unclassified Non Current Liabilities | — | 87,326,999USD | 92,302,000USD | 87,472,000USD | 84,083,000USD | 83,247,000USD | 92,793,000USD | 90,854,000USD |
| Unclassified Equity | — | 1,516,174,000USD | 1,466,474,001USD | 1,388,276,000USD | 1,385,473,000USD | 1,381,333,000USD | 1,377,773,000USD | 1,373,229,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 108,416,000USD | 164,418,000USD | 240,438,000USD | 358,172,000USD | 305,305,000USD | 313,050,000USD | 294,963,000USD | 341,192,000USD |
| Other Current Assets | 9,186,000USD | 12,275,000USD | 12,473,000USD | 20,885,000USD | 20,388,000USD | 559,000USD | 1,485,000USD | 6,413,000USD |
| Total Liab | 401,342,000USD | 350,435,000USD | 376,644,000USD | 374,828,000USD | 384,978,000USD | 262,504,000USD | 245,189,000USD | 158,022,000USD |
| Total Stockholder Equity | -292,926,000USD | -186,017,000USD | -136,206,000USD | -16,656,000USD | -79,673,000USD | 50,546,000USD | 49,774,000USD | 183,170,000USD |
| Other Current Liab | 66,078,000USD | 62,293,000USD | 63,048,000USD | 60,263,000USD | 69,799,000USD | -6,367,000USD | 41,378,000USD | 327,000USD |
| Common Stock | 14,000USD | 13,000USD | 12,000USD | 12,000USD | 8,000USD | 7,000USD | 7,000USD | 6,000USD |
| Capital Stock | 14,000USD | 13,000USD | 12,000USD | 12,000USD | 8,000USD | 7,000USD | 7,000USD | 6,000USD |
| Retained Earnings | -1,759,499,000USD | -1,563,460,000USD | -1,487,038,000USD | -1,343,939,000USD | -1,178,648,000USD | -1,069,611,000USD | -873,338,000USD | -673,748,000USD |
| Cash | 60,540,000USD | 62,476,000USD | 52,231,000USD | 135,188,000USD | 190,459,000USD | 85,918,000USD | 128,858,000USD | 118,021,000USD |
| Cash And Short Term Investments | 63,744,000USD | 108,712,000USD | 191,443,000USD | 277,967,000USD | 228,615,000USD | 273,455,000USD | 263,972,000USD | 328,199,000USD |
| Total Current Assets | 103,146,000USD | 156,492,000USD | 233,921,000USD | 350,162,000USD | 275,606,000USD | 289,539,000USD | 273,665,000USD | 334,612,000USD |
| Total Current Liabilities | 92,060,000USD | 92,264,000USD | 69,479,000USD | 65,908,000USD | 73,718,000USD | 297,000USD | 46,350,000USD | 46,904,000USD |
| Net Debt | 173,067,000USD | 132,048,000USD | 124,785,000USD | 43,886,000USD | -9,881,000USD | 32,010,000USD | -19,001,000USD | -15,357,000USD |
| Short Term Debt | 21,979,000USD | 24,864,000USD | 3,308,000USD | 2,872,000USD | 2,316,000USD | 1,917,000USD | 1,646,000USD | 32,883,000USD |
| Short Long Term Debt | 21,010,000USD | 24,426,000USD | — | — | — | — | — | — |
| Short Long Term Debt Total | 233,607,000USD | 194,524,000USD | 177,016,000USD | 179,074,000USD | 180,578,000USD | 119,845,000USD | 111,503,000USD | 135,547,000USD |
| Long Term Debt | 205,885,000USD | 162,948,000USD | 170,919,000USD | 170,105,000USD | 169,293,000USD | 117,928,000USD | 109,857,000USD | 102,664,000USD |
| Short Term Investments | 3,204,000USD | 46,236,000USD | 139,212,000USD | 142,779,000USD | 38,156,000USD | 163,322,000USD | 133,098,000USD | 210,178,000USD |
| Net Receivables | 26,178,000USD | 30,766,000USD | 26,962,000USD | 47,086,000USD | 22,497,000USD | 12,881,000USD | 7,862,000USD | — |
| Inventory | 4,038,000USD | 4,739,000USD | 3,043,000USD | 4,224,000USD | 4,106,000USD | 2,644,000USD | 346,000USD | — |
| Accounts Payable | 4,003,000USD | 5,107,000USD | 3,123,000USD | 2,773,000USD | 1,603,000USD | 4,450,000USD | 985,000USD | 4,332,000USD |
| Property Plant Equipment Net | 4,652,000USD | 6,284,000USD | 4,882,000USD | 7,377,000USD | 9,557,000USD | 2,219,000USD | 3,046,000USD | 3,863,000USD |
| Property Plant Equipment Gross | 10,162,000USD | 12,975,000USD | 11,447,000USD | 1,139,000USD | 1,642,000USD | 11,582,000USD | 13,663,000USD | 3,863,000USD |
| Accumulated Other Comprehensive Income | 71,000USD | -356,000USD | -161,000USD | -638,000USD | 191,000USD | 518,000USD | -37,000USD | -244,000USD |
| Common Stock Shares Outstanding | 10,935,000shares | 8,124,199shares | 7,614,733shares | 5,458,066shares | 5,014,533shares | 72,044,000shares | 61,955,420shares | 56,780,000shares |
| Non Current Assets Total | 5,270,000USD | 7,926,000USD | 6,517,000USD | 8,010,000USD | 29,699,000USD | 23,511,000USD | 21,298,000USD | 6,580,000USD |
| Non Current Liabilities Total | 309,282,000USD | 258,171,000USD | 307,165,000USD | 308,920,000USD | 311,260,000USD | 262,207,000USD | 245,189,000USD | 111,118,000USD |
| Non Current Liabilities Other | 11,095,000USD | 2,430,000USD | 978,000USD | 72,005,000USD | 82,687,000USD | 84,373,000USD | 86,790,000USD | — |
| Non Currrent Assets Other | 267,000USD | 1,642,000USD | 1,635,000USD | 633,000USD | 20,142,000USD | -2,923,000USD | 16,236,000USD | 716,000USD |
| Net Working Capital | 11,086,000USD | 64,228,000USD | 164,442,000USD | 284,254,000USD | 201,888,000USD | 216,328,000USD | 232,220,000USD | 287,708,000USD |
| Unclassified Current Liabilities | -21,010,000USD | -24,426,000USD | -25,066,000USD | — | -69,121,000USD | -6,367,000USD | — | — |
| Unclassified Non Current Liabilities | 92,302,000USD | 92,793,000USD | 135,268,000USD | 66,810,000USD | -156,405,000USD | -84,670,000USD | -29,430,000USD | -8,454,000USD |
| Unclassified Equity | 1,466,474,000USD | 1,377,773,000USD | 1,350,969,000USD | 1,327,897,000USD | 1,098,768,000USD | 1,119,625,000USD | 923,135,000USD | 857,150,000USD |
| Other Assets | — | — | 1USD | 633,000USD | 45,565,000USD | 34,300,000USD | 714,000USD | 716,000USD |
| Current Deferred Revenue | — | — | 25,066,000USD | — | 69,121,000USD | 297,000USD | 2,341,000USD | 9,362,000USD |
| Net Tangible Assets | — | — | — | -16,656,000USD | -79,673,000USD | 50,546,000USD | 49,774,000USD | 183,170,000USD |
| Other Liab | — | — | — | — | 215,685,000USD | 144,576,000USD | 75,780,000USD | 8,454,000USD |
| Long Term Investments | — | — | — | — | 0USD | 24,215,000USD | 2,016,000USD | 2,001,000USD |
| Unclassified Non Current Assets | — | — | — | — | -45,565,000USD | -37,223,000USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | 24,215,000USD | — | — |
| Deferred Long Term Liab | — | — | — | — | — | — | 2,192,000USD | 8,454,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 9,000USD |
| Stock Based Compensation | 4,936,000USD |
| Change To Account Receivables | -3,693,000USD |
| Change To Inventory | 44,000USD |
| Change To Liabilities | 7,167,000USD |
| Change In Working Capital | 1,786,000USD |
| Operating Cash Flow | -47,659,000USD |
| Net Investments | -6,836,000USD |
| Investing Cash Flow | -6,836,000USD |
| Common Stock Issuance | 574,000USD |
| Unclassified Financing Cash Flow | 48,330,000USD |
| Financing Cash Flow | 48,904,000USD |
| Effect Of Forex Changes On Cash | -2,000USD |
| Change In Cash | -5,593,000USD |
| End Cash Flow | 55,298,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -22,392,000USD | -102,198,000USD | -33,127,000USD | -37,252,000USD | -23,462,000USD | -30,780,000USD | -32,072,000USD | 23,792,000USD |
| Depreciation | 12,000USD | 2,464,000USD | 121,000USD | -42,000USD | 78,000USD | 2,438,000USD | 2,490,000USD | 91,000USD |
| Stock Based Compensation | 3,007,000USD | 3,903,000USD | 2,803,000USD | 3,784,000USD | 3,560,000USD | 3,864,000USD | 4,182,000USD | 5,410,000USD |
| Other Non Cash Items | -4,199,000USD | 78,503,000USD | 10,096,000USD | 4,763,000USD | -17,635,000USD | -11,416,000USD | -1,546,000USD | -58,317,000USD |
| Change To Account Receivables | 2,821,000USD | 5,699,000USD | 1,055,000USD | 2,311,000USD | -4,477,000USD | 1,012,000USD | 6,217,000USD | -6,913,000USD |
| Change To Inventory | 439,000USD | -72,000USD | 1,026,000USD | -223,000USD | -30,000USD | -67,000USD | -1,196,000USD | -707,000USD |
| Change In Working Capital | 3,851,000USD | 5,500,000USD | 14,247,000USD | 10,050,000USD | -1,525,000USD | 10,084,000USD | 7,493,000USD | -9,474,000USD |
| Total Cash From Operating Activities | -22,728,000USD | -11,828,000USD | -5,860,000USD | -18,697,000USD | -38,984,000USD | -25,810,000USD | -19,453,000USD | -38,498,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -53,000USD | 0USD | 0USD |
| Free Cash Flow | -22,728,000USD | -11,828,000USD | -5,860,000USD | -18,697,000USD | -38,984,000USD | -25,756,999USD | -19,453,000USD | -38,498,000USD |
| Investments | 3,200,000USD | 5,000,000USD | 4,805,000USD | 18,285,000USD | 15,288,000USD | 14,797,000USD | 7,474,000USD | 51,262,000USD |
| Total Cashflows From Investing Activities | 3,200,000USD | 5,000,000USD | 4,805,000USD | 18,285,000USD | 15,288,000USD | 14,797,000USD | 7,474,000USD | 51,262,000USD |
| Total Cash From Financing Activities | 49,802,000USD | 29,692,000USD | 0USD | 356,000USD | 0USD | 680,000USD | 0USD | 40,966,000USD |
| Issuance Of Capital Stock | 50,233,000USD | — | — | — | 0USD | — | — | — |
| Change In Cash | 30,310,000USD | 22,869,000USD | -1,053,000USD | -48,000USD | -23,691,000USD | -10,353,000USD | -11,943,000USD | 53,719,000USD |
| Begin Period Cash Flow | 60,540,000USD | 38,022,000USD | 39,075,000USD | 39,123,000USD | 62,814,000USD | 73,167,000USD | 85,110,000USD | 31,087,000USD |
| End Period Cash Flow | 90,850,000USD | 60,891,000USD | 38,022,000USD | 39,075,000USD | 39,123,000USD | 62,814,000USD | 73,167,000USD | 84,806,000USD |
| Other Cashflows From Financing Activities | -431,000USD | — | — | 356,000USD | — | 680,000USD | -118,697,000USD | 40,966,000USD |
| Unclassified Operating Cash Flow | -3,007,000USD | — | — | — | — | — | — | — |
| Net Borrowings | — | 27,000,000USD | 0USD | — | — | 40,518,000USD | 0USD | — |
| Unclassified Financing Cash Flow | — | 2,692,000USD | — | — | — | -40,518,000USD | 7,697,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 14,744,000USD | 7,474,000USD | 51,262,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | -14,691,000USD | -7,474,000USD | -51,262,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 111,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -196,039,000USD | -76,422,000USD | -143,099,000USD | -165,291,000USD | -124,088,000USD | -196,273,000USD | -199,590,000USD | -178,407,000USD |
| Depreciation | -114,000USD | 340,000USD | 530,000USD | 621,000USD | 789,000USD | 972,000USD | 974,000USD | 735,000USD |
| Stock Based Compensation | 14,050,000USD | 18,426,000USD | 21,709,000USD | 35,399,000USD | 29,783,000USD | 24,407,000USD | 15,291,000USD | 17,275,000USD |
| Other Non Cash Items | 78,462,000USD | -69,528,000USD | -3,278,000USD | -294,000USD | 8,135,000USD | 8,400,000USD | 7,193,000USD | 1,420,000USD |
| Change To Account Receivables | 4,588,000USD | -3,804,000USD | 20,124,000USD | -5,084,000USD | -9,616,000USD | -5,019,000USD | -7,862,000USD | -7,862,000USD |
| Change To Inventory | 701,000USD | -1,696,000USD | 1,181,000USD | -118,000USD | -1,462,000USD | -2,627,000USD | -346,000USD | -346,000USD |
| Change In Working Capital | 28,272,000USD | -302,000USD | 31,415,000USD | -19,989,000USD | -23,189,000USD | 1,356,000USD | -13,308,000USD | -169,000USD |
| Total Cash From Operating Activities | -75,369,000USD | -127,486,000USD | -92,723,000USD | -149,554,000USD | -107,116,000USD | -160,234,000USD | -190,822,000USD | -159,117,000USD |
| Capital Expenditures | 0USD | -142,000USD | 0USD | -118,000USD | -5,712,000USD | -145,000USD | -206,000USD | -2,363,000USD |
| Free Cash Flow | -75,369,000USD | -127,628,000USD | -92,723,000USD | -149,672,000USD | -112,828,000USD | -160,379,000USD | -191,028,000USD | -161,480,000USD |
| Investments | 43,378,000USD | 95,473,000USD | -84,201,000USD | -104,138,000USD | 147,552,000USD | -53,540,000USD | 78,656,000USD | -105,301,000USD |
| Total Cashflows From Investing Activities | 43,378,000USD | 95,473,000USD | 7,940,000USD | -104,256,000USD | 141,840,000USD | -53,685,000USD | 78,450,000USD | -107,664,000USD |
| Net Borrowings | 27,000,000USD | 83,300,000USD | 0USD | 0USD | — | — | — | 166,885,000USD |
| Total Cash From Financing Activities | 30,048,000USD | 41,646,000USD | 1,124,000USD | 193,738,000USD | 73,648,000USD | 172,083,000USD | 124,305,000USD | 316,109,000USD |
| Issuance Of Capital Stock | 8,750,000USD | 0USD | 154,679,000USD | 189,761,000USD | 9,903,000USD | 161,776,000USD | 46,191,000USD | 145,705,000USD |
| Change In Cash | -1,923,000USD | 9,622,000USD | -83,693,000USD | -60,560,000USD | 108,324,000USD | -41,568,000USD | 11,952,000USD | 49,250,000USD |
| Begin Period Cash Flow | 62,814,000USD | 53,192,000USD | 136,885,000USD | 197,445,000USD | 89,121,000USD | 130,689,000USD | 118,737,000USD | 69,487,000USD |
| End Period Cash Flow | 60,891,000USD | 62,814,000USD | 53,192,000USD | 136,885,000USD | 197,445,000USD | 89,121,000USD | 130,689,000USD | 118,737,000USD |
| Other Cashflows From Financing Activities | 30,048,000USD | -43,106,000USD | 1,124,000USD | 3,977,000USD | 3,745,000USD | 10,307,000USD | 78,114,000USD | 3,519,000USD |
| Unclassified Financing Cash Flow | -35,750,000USD | -109,548,000USD | -154,679,000USD | 185,784,000USD | 66,158,000USD | 151,469,000USD | 41,686,000USD | 142,186,000USD |
| Sale Purchase Of Stock | — | 111,000,000USD | — | 3,977,000USD | 3,745,000USD | 10,307,000USD | 4,505,000USD | 3,519,000USD |
| Unclassified Investing Cash Flow | — | — | 92,141,000USD | 104,256,000USD | 5,500,000USD | 53,540,000USD | -78,656,000USD | 105,301,000USD |
| Change To Liabilities | — | — | — | -8,366,000USD | 13,413,000USD | 15,626,000USD | 5,211,000USD | 9,875,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -60,072,000USD | 108,372,000USD | -41,836,000USD | 11,933,000USD | 49,328,000USD |
| Other Cashflows From Investing Activities | — | — | — | -104,256,000USD | -5,500,000USD | -53,540,000USD | 78,656,000USD | -105,301,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 1,454,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2023Quarterly · 2023-09-30 | Product | License And Other | 5,802,000 | USD | 0000950170-24-121076 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | 30,207,000 | USD | 0000950170-24-121076 |
| Q1 2022Quarterly · 2022-03-31 | Product | License And Other | 19,370,000 | USD | 0000950170-23-017483 |
| Q1 2022Quarterly · 2022-03-31 | Product | Product | 28,300,000 | USD | 0000950170-23-017483 |
| Q1 2022Quarterly · 2022-03-31 | Product | Royalty | 300,000 | USD | 0000950170-23-017483 |
| Q4 2021Quarterly · 2021-12-31 | Product | License And Other | 96,466,000 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-12-31 | Product | Product | 29,803,000 | USD | Legacy provider |
| FY 2021Yearly · 2021-12-31 | Product | License And Other | 111,383,000 | USD | 0000950170-24-022650 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 98,436,000 | USD | 0000950170-24-022650 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 800,000 | USD | 0000950170-24-022650 |
| Q3 2021Quarterly · 2021-09-30 | Product | License And Other | 10,966,000 | USD | 0000950170-22-021917 |
| Q3 2021Quarterly · 2021-09-30 | Product | Product | 26,723,000 | USD | 0000950170-22-021917 |
| Q3 2021Quarterly · 2021-09-30 | Product | Royalty | 200,000 | USD | 0000950170-22-021917 |
| Q2 2021Quarterly · 2021-06-30 | Product | License And Other | 2,422,000 | USD | 0000950170-22-014788 |
| Q2 2021Quarterly · 2021-06-30 | Product | Product | 20,179,000 | USD | 0000950170-22-014788 |
| Q2 2021Quarterly · 2021-06-30 | Product | Royalty | 100,000 | USD | 0000950170-22-014788 |
| Q1 2021Quarterly · 2021-03-31 | Product | License And Other | 1,529,000 | USD | 0000950170-22-007564 |
| Q1 2021Quarterly · 2021-03-31 | Product | Product | 21,731,000 | USD | 0000950170-22-007564 |
| Q4 2020Quarterly · 2020-12-31 | Product | License And Other | 14,882,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Product | Product | 20,218,000 | USD | Legacy provider |
| FY 2020Yearly · 2020-12-31 | Product | License And Other | 31,875,000 | USD | 0000950170-23-003129 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 76,210,000 | USD | 0000950170-23-003129 |
| Q3 2020Quarterly · 2020-09-30 | Product | License And Other | 3,000 | USD | 0000950170-21-002729 |
| Q3 2020Quarterly · 2020-09-30 | Product | Product | 21,330,000 | USD | 0000950170-21-002729 |
| FY 2019Yearly · 2019-12-31 | Product | License And Other | 10,353,000 | USD | 0000950170-22-002548 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 30,540,000 | USD | 0000950170-22-002548 |
| FY 2018Yearly · 2018-12-31 | Product | License And Other | 30,336,000 | USD | 0001193125-21-054811 |
| FY 2018Yearly · 2018-12-31 | Product | Product | 0 | USD | 0001193125-21-054811 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.